Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral Naltrexone Therapy in Opiate Dependence
NCT00238914Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 1999
- Primary completion
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Aug 1999; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00238914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238914.